Press release
Hematuria Treatment Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Johnson & Johnson, Cipla Ltd, Pfizer Inc., Aurobindo Pharma USA, Zambon USA Ltd., GlaxoSmithKline plc
Hematuria Treatment Market - DataM Intelligence
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/hematuria-treatment-market?sg
Industry Recent Developments 2025:
✅ 12 Jun 2025 - FDA approves UroGen's intravesical mitomycin product ZUSDURI (first FDA-approved mitomycin intravesical solution for recurrent low-grade, intermediate-risk NMIBC).
✅ 27 Feb 2025 - AUA/SUFU publishes the 2025 Microhematuria Guideline Amendment (refines risk stratification and, for the first time, permits use of validated urine-based tumor markers in appropriately counseled intermediate-risk patients).
✅ 28 Feb 2025 - Pacific Edge / Cxbladder announcement: Cxbladder Triage is specifically named in the AUA microhematuria amendment and described as the urine biomarker with highest supporting evidence ("Grade A" in the guideline context).
✅ 29 Apr 2025 - AUA 2025 plenary/conference reports: real-world evaluations (Kaiser Permanente and others) and presentations showing Cxbladder Triage/Triage Plus utility in triaging hematuria patients - strengthens clinical uptake of urine-based diagnostics to reduce unnecessary cystoscopy.
✅ 24 Mar 2025 - EAU 2025 highlights: EpiCheck-triggered photodynamic diagnosis and other enhanced cystoscopy adjuncts were presented as methods that detect high-grade recurrences missed by standard white-light cystoscopy - relevant to hematuria diagnostic pathways.
✅ 9 Apr 2025 - Growth-equity activity: General Atlantic makes a growth investment in U.S. Urology Partners (strengthening practice consolidation / MSO networks that influence referral patterns and service delivery for hematuria evaluation).
✅ (Apr-Jun 2025) Diagnostics & imaging vendor momentum: multiple vendors showcased upgraded cystoscopy/ureteroscopy imaging systems and noninvasive urine-test validation data across conferences in 2025 industry push to de-intensify invasive hematuria workups where appropriate.
✅ 12 Aug 2025 - (major MSO deal affecting urology care consolidation) Cardinal Health announced agreement to acquire Solaris Health (a large urology MSO) - transaction expands multi-specialty/MSO footprints that will affect urology service networks and hematuria care delivery.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hematuria-treatment-market?sg
Key market growth drivers:
✅ Rising prevalence of urological disorders & ageing populations - growing incidence of bladder cancer, recurrent UTIs, kidney stones and age-related urologic conditions increases demand for hematuria diagnosis and treatment.
✅ Improved diagnostics and minimally invasive therapies - wider adoption of cystoscopy (including single-use cystoscopes), advanced imaging and endoscopic treatments raises diagnosis rates and expands treatment pathways.
✅ Greater awareness and screening / earlier detection - screening programs and guideline-driven evaluation of microscopic/macroscopic hematuria lead to more investigations and downstream treatment interventions.
✅ R&D, pipeline activity and device innovation - investment in urology devices, disposable/endoscopic tools and therapeutic pipelines supports market expansion and creates new commercial opportunities.
Regional share & dynamics:
➠ North America - largest share (~~35-40%): The United States leads because of advanced healthcare infrastructure, high healthcare spend, established urology centers and broad adoption of diagnostic/therapeutic technologies. Several market reports identify North America as the dominant regional market.
➠ Europe - second largest: Strong clinical research activity, reimbursement coverage and demand for novel therapies keep Europe as a major market (notably Germany, UK, France).
➠ Asia-Pacific - fastest-growing: Higher unmet need, expanding healthcare access, rising disease burden and investments in diagnostics make APAC the fastest-growing region (China and India singled out by several sources).
Segments Covered in the Hematuria Treatment Market:
By Type (Drugs, Therapies)
By Disease Type (Microscopic Hematuria, Gross Hematuria)
By End-User (Hospitals, Specialty Clinics, Other)
Regional Analysis for Hematuria Treatment Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=hematuria-treatment-market?sg
Major Key Players: Johnson & Johnson, Cipla Ltd., Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co., Pfizer Inc., Aurobindo Pharma USA, Zambon USA Ltd., GlaxoSmithKline plc.
Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription?sg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematuria Treatment Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Johnson & Johnson, Cipla Ltd, Pfizer Inc., Aurobindo Pharma USA, Zambon USA Ltd., GlaxoSmithKline plc here
News-ID: 4285290 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Digital Twins in the Oil and Gas Market to hit $ 2.81 billion by 2032 | Major Ma …
The Global Digital Twins in the Oil and Gas Market reached US$ 1.2 billion in 2024 and is projected to reach US$ 2.81 billion by 2032, growing at a CAGR of 11.20% during the forecast period 2025-2032.
DataM Intelligence unveils exclusive insights into the Global Digital Twins in the Oil and Gas Market 2026, highlighting the adoption of advanced simulation technologies, predictive analytics, integrated asset monitoring, and real-time process optimization across…
Microgrid-as-a-Service Market to Reach USD 8.3 Billion by 2032 at 12.9% CAGR | N …
The Microgrid-as-a-Service (MaaS) Market was valued at USD 3.1 billion in 2024 and is projected to reach USD 8.3 billion by 2032, expanding at a CAGR of 12.9% during the forecast period from 2025 to 2032. This strong growth reflects rising global demand for reliable, resilient, and low-carbon energy solutions across industrial, commercial, and institutional sectors. Increasing urbanization, expansion of energy-intensive facilities, and the need to reduce dependence on centralized…
Wi-Fi Router Market to Reach USD 26.57 Billion by 2032 at 9.4% CAGR | Asia Pacif …
The Wi-Fi Router Market was valued at USD 14.28 billion in 2024 and is projected to reach USD 26.57 billion by 2032, expanding at a CAGR of 9.4% during the forecast period from 2025 to 2032. This growth reflects increasing global demand for high-speed, reliable wireless connectivity driven by the rapid adoption of smart homes, remote work, online education, streaming services, and IoT-enabled devices. As network performance expectations rise, consumers…
Managed Detection and Response Market to Reach USD 16.88 Billion by 2032 at 28.6 …
The Managed Detection and Response (MDR) Market was valued at USD 4.25 billion in 2024 and is projected to reach USD 16.88 billion by 2032, expanding at a CAGR of 28.6% during the forecast period from 2025 to 2032. This rapid growth reflects the escalating complexity and frequency of cyber threats, increasing regulatory mandates for robust security, and rising enterprise demand for outsourced, expert-driven threat detection and response capabilities. As…
More Releases for Hematuria
The Hidden Goldmine: Exploring the Untapped Hematuria Treatment Market
The Hematuria Treatment Market sector is undergoing significant transformation, with substantial growth and technological advancements expected by 2031. According to a new in-depth market research report, the sector is poised for expansion, driven by various factors such as market size, share, and emerging trends.
This comprehensive report provides key insights into the Hematuria Treatment market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering a clear…
Hematuria Treatment Market Global Rising Demand & Huge Scope Till 2031
Hematuria Treatment Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.…
Hematuria Treatment Market Growth, Future Prospects And Competitive Analysis (20 …
The Hematuria Treatment Market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is estimated to grow at a CAGR of 2.4% from 2020 to 2028.
Factors such as the high prevalence of hematuria-associated indications, and increasing awareness about treatment options and improving healthcare expenditure are driving the market growth. However, the undiagnosed cases of associated indications affect the effectiveness of hematuria treatments, thereby…
Hematuria Market Size, Epidemiology, Analysis & Trends 2023-2033
Hematuria Market Report Overview:
Report Attribute Details
Base Year …
Hematuria Treatment Market Insight And Comprehensive Analysis By 2028
Hematuria Treatment Market research study 2022-2028 enhances the decision-making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at the insight partners. Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Request sample pages of this research study at-
https://www.theinsightpartners.com/sample/TIPRE00004601/?utm_source=OpenPR&utm_medium=10366
The hematuria treatment market is projected to reach US$ 1,103.61 million by 2028 from US$…
Hematuria Treatment Market Overview, Application and Geographical Segmentation 2 …
Market Highlights
The Global Hematuria treatment market has been examined as a growing market and expected to develop at a tremendous rate. There is huge demand for Hematuria treatment in North American countries like US and Canada. Growing incidence rate of various types of Hematuria and increasing number of traumatic injury cases are some of the factors driving the growth of the market. Further factors such as the risks involved in…
